



EARLY LACTATE-DIRECTED THERAPY IN CRITICALLY ILL PATIENTS
ADMITTED TO THE INTENSIVE CARE: A RANDOMIZED CONTROLLED
MULTI-CENTRE TRIAL
T. Jansen1, J. Van Bommel1, J. Schoonderbeek2, S. Sleeswijk Visser3, J. Van der Klooster4,
A. Lima1, S. Willemsen5, J. Bakker1, LACTATE Study Group
1Erasmus Medical Center, Intensive Care Medicine, Rotterdam, Netherlands, 2Ikazia Hos-
pital, Intensive Care Medicine, Rotterdam, Netherlands, 3Reinier de Graaf Hospital, Intensive
Care Unit, Delft, Netherlands, 4Sint Franciscus Gasthuis, Intensive Care Medicine, Rotter-
dam, Netherlands, 5Erasmus Medical Center, Biostatistics, Rotterdam, Netherlands
INTRODUCTION. Hyperlactatemia in critically ill patients is associated with increased
mortality. However, it is unknown whether the use of lactate clearance as a resuscitation
endpoint improves survival.
OBJECTIVE. The primary objective of this multi-centre study was to assess the effect of
lactate-directed therapy on hospital mortality, in patients admitted to the ICU with a lactate
level of C3.0 mmol/l.
METHODS. We randomly allocated patients with hyperlactatemia to either lactate-directed
therapy or non-lactate directed therapy during the first 8 h of ICU stay. Hospital mortality
(primary outcome), resuscitation endpoints, administered therapy, organ failure and use of
health care resources were compared between the two groups.
RESULTS. In the intention-to-treat population of 348 patients, early lactate-directed therapy
did not significantly reduce in-hospital mortality as compared with non-lactate directed
therapy (33.9% vs. 43.5%, p = 0.067). However, when corrected for predefined risk factors,
hospital mortality was lower in patients assigned to early lactate-directed therapy (hazard ratio
0.61, 95% CI 0.43–0.87, p = 0.006). Additionally, early lactate-directed therapy resulted in a
lower SOFA score between 9 and 72 h, earlier discharge from the ICU, earlier weaning from
mechanical ventilation and earlier cessation of inotropes.
CONCLUSION. The use of lactate-directed therapy in the initial resuscitation of critically ill
patients admitted to the ICU with increased blood lactate levels reduces hospital mortality in an
intention-to-treat analysis corrected for predefined risk factors. In addition lactate-directed
therapy significantly decreases organ failure and the use of health care resources in these patients.
TRIAL REGISTRATION. ClinicalTrial.gov number NCT00270673.
0823
A RANDOMISED CONTROLLED TRIAL OF THE EFFECTS OF POST-OPERA-
TIVE HAEMODYNAMIC OPTIMISATION ON MICROVASCULAR FLOW, TISSUE
OXYGENATION AND INFLAMMATORY MARKERS AFTER MAJOR ABDOMI-
NAL SURGERY
S. Jhanji1, A. Vivian-Smith1, S. Lucena-Amaro1, D. Watson1, C. J. Hinds1, R. M. Pearse1
1Barts and The London School of Medicine and Dentistry, William Harvey Research Insti-
tute, London, United Kingdom
INTRODUCTION. Perioperative Goal Directed Haemodynamic Therapy (GDHT) appears
to improve outcome [1]. Importantly, the biological mechanisms underlying these beneficial
effects have not been investigated.
OBJECTIVES. To assess the effects of three haemodynamic regimens on tissue microvas-
cular flow and oxygenation in patients after major abdominal surgery.
METHODS. Approval from the local ethics committee and the competent authority were
granted. Patients were randomised to receive one of three haemodynamic protocols for 8 h
immediately after major abdominal surgery. The central venous pressure (CVP) group
received intravenous (iv) colloid boluses to achieve a sustained rise in CVP. The stroke
volume (SV) group received iv colloid boluses to achieve a sustained rise in SV. In the SV
plus dopexamine group, patients received iv colloid boluses to achieve a sustained rise in SV
plus a fixed rate infusion of dopexamine (0.5 lg/kg/min). Data collected included oxygen
delivery index (DO2I) (lithium dilution & pulse power analysis), mean arterial pressure
(MAP), sublingual microvascular flow videos (sidestream darkfield imaging), cutaneous
microvascular flow (laser Doppler), cutaneous tissue PtO2 (Clark electrode) and serum levels
of Il-1b, Il-6, Il-8, TNF-a and ICAM-1. Data are presented as mean (SD) or median (IQR).
*p \ 0.05, **p \ 0.01 over time. p \ 0.05, p \ 0.01 vs CVP group.
RESULTS. 135 patients were recruited. SV guided fluid therapy with dopexamine was
associated with a significant increase in DO2I, ScvO2, sublingual and cutaneous microvas-
cular flow and tissue PtO2 but no difference in serum inflammatory markers. There were no
siginificant differences in morbidity, mortality or hospital stay (Tables 1, 2, 3).
TABLE 1 PATIENT DEMOGRAPHICS AND OUTCOMES
CVP group SV group SV plus dopexamine
group
n 45 45 45
Age (years) 70 (64–78) 68 (59–77) 65 (59–74)
P-POSSUM 40 (34–44) 35 (31–40) 34 (31–40)
Complications (n [%]) 30 (67%) 26 (58%) 31 (69%)
Hospital stay (days) 15 (10–26) 14 (11–26) 16 (11–28)
Hospital mortality (n [%]) 6 (13%) 5 (11%) 4 (9%)
CVP group SV group SV plus dopexamine
group
MAP hour 0 (mmHg) 80 (22) 76 (15) 80 (18)
MAP hour 8 (mmHg) 77 (14) 77 (14) 74 (12) **
DO2I hour 0 (ml/min/m
2) 477 (146) 449 (145) 498 (157)
DO2I hour 8 (ml/min/m
2) 467 (159) 484 (150)*, 614 (209)**,
ScvO2 hour 0 (%) 73 (10) 73 (7) 70 (11)
ScvO2 hour 8 (%) 73 (7) 74 (6) 78 (8)**
,
* p \ 0.05, ** p \ 0.01 over time.  p \ 0.05,  p \ 0.01 vs CVP group
CVP
group
SV group SV plus
dopexamine
group
Change in sublingual perfused vessel density
during intervention (n/mm)
-0.8 (1.7) +0.1 (2.0) +0.5 (2.5)
Change in cutaneous reactive hyperaemia
ratio during intervention
-0.7 (1.3) 0.0 (2.3) +1.4 (2.7)
Change in PtO2 during intervention (kPa) 0.0 (2.9) +0.5 (3.4) +1.7 (3.7)
 p \ 0.05,  p \ 0.01 vs CVP group
CONCLUSIONS. Post-operative GDHT with dopexamine improves global haemodynamics,
tissue microvascular flow and oxygenation. Systemic inflammatory markers were unchanged.
REFERENCES. 1. Pearse et al (2005) Crit Care 9:R687–R693
2. Jhanji et al (2009) Intensive Care Med 35:671–677
GRANT ACKNOWLEDGEMENT. ESICM/ECCRN Spacelabs Intelligent Monitoring
Award 2006
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INVERSE CORRELATION BETWEEN NITROGLYCERIN-INDUCED CHANGES
IN CENTRAL-PERIPHERAL TEMPERATURE GRADIENT AND CHANGES IN
SUBLINGUAL PERFUSED CAPILLARY DENSITY IN PATIENTS WITH CARDIO-
GENIC SHOCK OR END-STAGE CHRONIC HEART FAILURE
C. den Uil1, W. Lagrand2, M. van der Ent1, L. Jewbali1, P. Spronk3, M. Simoons1
1Erasmus Medical Center, Rotterdam, Netherlands, 2Academic Medical Center at the Uni-
versity of Amsterdam, Amsterdam, Netherlands, 3Gelre Hospitals, Apeldoorn, Netherlands
OBJECTIVE. To investigate the correlation between nitroglycerin-induced changes in
central-peripheral temperature gradient and changes in sublingual perfused capillary den-
sity in patients with cardiogenic shock or end-stage chronic heart failure.
METHODS. A nitroglycerin dose-response study was performed in fifteen patients with
cardiogenic shock (n = 9) or end-stage chronic heart failure (n = 6) admitted to Erasmus
University Medical Center. We did hemodynamic measurements at baseline and during
increasing infusion rates of nitroglycerin (up to a maximum dose of 133 lg min-1). As
parameters of tissue perfusion, we measured central-peripheral temperature gradient (delta-
T) and sublingual perfused capillary density (PCD). Sublingual PCD was measured
with SDF imaging and AVA 3.0 software. Capillaries were defined as micro-vessels
with a diameter of \20 lm. We pooled all nitroglycerin-induced changes in delta-T and
PCD.
RESULTS. Nitroglycerin dose-dependently decreased mean arterial pressure (p = 0.01),
cardiac filling pressures (central venous pressure: p \ 0.001; pulmonary capillary wedge
pressure: p = 0.001), and mixed-venous oxygen saturation (p = 0.02). Nitroglycerin
decreased delta-T (p \ 0.001) and improved sublingual PCD (p \ 0.001). Macro-hemody-
namic and microcirculatory responses to nitroglycerin infusion were consistent in patients
with either cardiogenic shock or end-stage chronic heart failure. A significant correlation was
found between pooled changes in both parameters of tissue perfusion (Spearman r = -0.48,
p \ 0.001; Fig. 1).
Fig. 1
CONCLUSIONS. Nitroglycerin dose-dependently increased tissue perfusion, measured by
two independent parameters. There was a significant correlation between induced changes in
both parameters of tissue perfusion.
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VASOPRESSIN, EPINEPHRINE, AND CORTICOSTEROIDS FOR INHOSPITAL
CARDIAC ARREST [NCT00729794]
S. D. Mentzelopoulos1, G. Chamos1, T. Taidou1, D. Konstantopoulos2, A. Lomaka2,
V. Mintzi3, E. Sika3, G. Ganeli3, K. Koutsodimou3, D. Makris4, S. Sourlas5
1University of Athens, Intensive Care Medicine, Athens, Greece, 2Evaggelismos Hospital,
Department of Anesthesiology, Athens, Greece, 3University of Larissa, Anesthesiology,
Larissa, Greece, 4University of Larissa, Intensive Care Medicine, Larissa, Greece, 5401
General Army Hospital Athens, Anesthesiology and Intensive Care Medicine, Agia Paraskevi,
Greece
INTRODUCTION. The addition of vasopressin during cardiopulmonary resuscitation (CPR)
and of steroids during and after CPR may increase the rates of return of spontaneous circu-
lation (ROSC) and improve post-arrest survival [1]. We seek to provide definitive evidence
supporting this hypothesis and its generalizability by adequately increasing the size of the
originally studied population [1] in the context of a three-center, randomized, controlled trial.
Herein, we report the results of the second interim analysis.
METHODS. Adult in-patients with cardiac arrest were randomized to receive either (1)
vasopressin (20 IU/CPR cycle for 5 cycles) plus epinephrine (1 mg/CPR cycle) plus meth-
ylprednisolone (single dose = 40 mg on the first CPR cycle) (study group); or (2) placebo
plus epinephrine plus placebo (control group). Following return of spontaneous circulation
(ROSC), study group patients with postresuscitation shock also received stress dose hydro-
cortisone (300 mg/day for 3–7 days and then gradual taper), whereas controls received
placebo. Primary endpoints were ROSC for at least 15 min, and survival to discharge either to
home or to a rehabilitation facility.
RESULTS. Data from 180 patients were analyzed. Patient clinical profiles were similar.
Study group patients vs. controls had higher mean arterial pressure during and after CPR
[mean (SD), 75.1 (21.9) vs. 50.4 (13.0) mm Hg and 94.3 (37.2) vs. 70.7 (22.2) mm
Hg, p \ 0.001], and higher rates of ROSC (71/85 vs. 55/95, p \ 0.001) and discharge to
either home or a rehabilitation/high dependency unit (15/85 vs. 5/95, p = 0.009).
CONCLUSION. These results indicate improved study group survival. The study is con-
tinued according to an interim analysis stopping rule of adjusted p \ 0.001.
GRANT ACKNOWLEDGEMENT. Supported in part by the Thorax Foundation.
REFERENCE. 1. Mentzelopoulos SD et al. (2009) Arch Intern Med 169:15–24
22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009 S213
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COMBINATION OF STATIC AND FUNCTIONAL PRELOAD PARAMETERS
ENABLES EARLY DETECTION OF RIGHT VENTRICULAR FAILURE
H. P. Richter1, D. A. Reuter1, C. Petersen1, A. E. Goetz1, J. C. Kubitz1
1University Medical Center Hamburg-Eppendorf, Department of Anaesthesiology, Hamburg,
Germany
AIMS. Diagnosis of right ventricular dysfunction (RVD) or failure is often delayed or
missed. In case of RVD, optimization of cardiac preload is essential for providing hemo-
dynamic stability. So far, static right ventricular (RV) preload parameters such as central
venous pressure (CVP) or RV end-diastolic volume (RVEDV) are used to assess cardiac
preload in RVD. As the interdependence of RV and left ventricular (LV) function is
supposed to be reflected in the relationship of RV and LV preload parameters, we now
investigated in an experimental model whether the combination static RV and functional
LV preload parameters can be used for early detection of RVD and for guidance of volume
therapy.
METHODS. After approval by the local governmental commission, fifteen anesthetized
pigs (29 ± 0.8 kg) were examined. CVP, RV end-diastolic pressure (RVEDP) and mean
arterial pressure (MAP) were recorded using micro-tip catheters. Mean pulmonary artery
pressure (MPAP) and RVEDV were measured by a thermodilution pulmonary artery
catheter (VOLEF, Pulsion, Germany). Pulse pressure variation (PPV) and stroke volume
variation (SVV) (derived from an ultrasonic flowprobe on the ascending aorta) were
calculated over 5 respiratory cycles. Cardiac output (CO) was derived from a pulmonary
artery flowprobe. After a baseline measurement, RVD was induced by increasing MPAP
by 50% by continuous infusion of the thromboxan-analogon U46619. Then, 300 ml
blood were extracted (vol.extraction), followed by a volume challenge (600 ml)
(vol.challenge).
RESULTS. The increase in RV afterload resulted in a reduction of MAP and CO. CVP, SVV
and PPV increased, while heart rate (HR), RVEDP and RVEDV remained unchanged. Vol-
ume extraction decreased MAP, MPAP, CVP and RVEDP without changes in SVV or PPV.
During the volume challenge, MAP, MPAP, CVP, RVEDP and RVEDV increased again,
without significant changes in CO, SVV or PPV.
TABLE 1 RESULTS
Baseline RVD Vol. extraction Vol. challenge
HR (beats/min) 96 (15) 98 (16) 100 (19) 100 (15)
MPAP (mmHg) 25.1 (3.3) 37.4 (4.9)** 34.1 (6.4) 41.8 (7.8)#
MAP (mmHg) 72.2 (14.1) 60.1 (11.3)** 53.2 (10.6) 63.7 (9.1)#
CO (l/min) 2.8 (0.6) 2.3 (0.7)** 2.1 ± (0.7) 2.3 ± (0.6)
CVP (mmHg) 11.3 (4.6) 12.6 (4.7)* 10.3 (4.7) 14.8 (6.0)#
RVEDP (mmHg) 13.8 (4.6) 14.7 (5.8) 11.4 (4.9) 16.6 (3.6)#
RVEDV (ml) 112 (27) 110 (19) 108 (23) 124 (19)#
SVV (%) 11 (3) 14 (4)* 14 (5) 13 (4)
PPV (%) 13 (4) 17 (6)* 16(7) 15 (5)
Mean values (standard deviation) are presented; * p \ 0.05 vs. baseline;
** p \ 0.001 vs. baseline;  p \ 0.001 vs. RVD; # p \ 0.05 vs. vol.extraction
CONCLUSIONS. A simultaneous increase in both static RV (CVP) and functional LV
preload parameters (SVV, PPV) seems indicative for RVD. Further diagnosis is warranted.
Continuous registration of CVP and SVV or PPV may provide an early indicator of RVD and
help to guide volume therapy in RVD.
Acute lung injury: Pathophysiology: 0827–0831
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THE SELECTIVE a7NACHR AGONIST GTS-21 ATTENUATES VENTILATOR-
INDUCED INFLAMMATION AND LUNG INJURY
M. Kox1, J.C. Pompe1, M. Vaneker2, L.M. Heunks1, J. G. van der Hoeven1,
C. W. Hoedemaekers1, P. Pickkers1
1Radboud University Nijmegen Medical Centre, Intensive Care Medicine, Nijmegen,
Netherlands, 2Radboud University Nijmegen Medical Centre, Anesthesiology, Nijmegen,
Netherlands
INTRODUCTION. Mechanical ventilation (MV) induces an inflammatory response that
contributes to lung injury such as in ALI or ARDS. The efferent vagus nerve can limit the
inflammatory response via the a7 nicotinic acetylcholine receptor (a7nAChR), the so-called
cholinergic anti-inflammatory pathway. The aim of this study was to evaluate the effect of the
selective a7nAChR agonist GTS-21 on pulmonary and systemic inflammation and lung injury
induced by MV using clinically relevant ventilator settings.
METHODS. C57BL6 mice (n = 40) were i.p. injected with 8 mg/kg GTS-21 or placebo
after which they were mechanically ventilated for 4 h (tidal volume 8 ml/kg; PEEP 1.5 cm
H2O; FiO2 0.45). Untreated, not mechanically ventilated mice were used as controls. Mean
arterial pressure (MAP) and rectal temperature were monitored throughout the ventilation
period. Arterial blood gases were obtained at the end of the experiment and TNF-a, IL-6, IL-
1a, IL-1b, KC and IL-10 were determined in plasma and lung homogenates. Lung TNF-a and
IL-10 mRNA expression was measured in lung homogenates using quantitative PCR.
RESULTS. MAP and rectal temperature did not differ between GTS-21 and placebo-treated
animals. In GTS-21-treated mice, the alveolar-arterial (A-A) gradient after MV was signifi-
cantly reduced compared to placebo (18.7 ± 0.8 vs. 20.8 ± 0.6 kPa; p = 0.04). MV resulted
in an increase of all cytokines in plasma and lung compared to control mice. TNF-a was
significantly lower in plasma of GTS-21-treated animals compared to placebo (196.2 ± 50.8
vs. 331.9 ± 31.9 pg/ml; p = 0.04). Similarly, in lung homogenates a distinct trend was
observed towards lower TNF-a levels in GTS-21-treated mice (53.9 ± 12.5 vs.
79.1 ± 5.6 pg/mg protein; p = 0.06). IL-10 levels were unaffected by GTS-21. MV strongly
increased TNF-a mRNA expression in lungs of placebo animals (21-fold compared to con-
trols), this was significantly lower in GTS-21-treated mice (12-fold compared to controls;
p = 0.02). IL-10 mRNA expression was similar in GTS-21-treated and placebo animals.
CONCLUSION. MV with clinically relevant ventilator settings results in activation of the
immune system. GTS-21 inhibits pro-inflammatory cytokine production while not affecting
the anti-inflammatory cytokine IL-10.The reduced A-A gradient in GTS-21-treated animals
indicates attenuation of lung injury. In conclusion, limiting the inflammatory response appears
to reduce lung injury and therefore the cholinergic anti-inflammatory pathway may represent
new treatment options for MV-induced lung injury.
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PHOSPHOINOSITIDE 3 KINASE BETA ATTENUATES INFLAMMATION AND
FIBROSIS IN A BLEOMYCIN MODEL OF ACUTE LUNG INJURY
V. Fanelli1, E. Ciraolo2, M. Bosco3, L. Delsedime3, A. Mensa1, E.L. Martin1, L. Delsorbo1,
B. Assenzio1, M. L. Campanari1, E. Hirsch2, V. M. Ranieri1
1Universita` di Torino, Dept. of Anaesthesiology and Critical Care Medicine, Torino, Italy,
2Universita` di Torino, Department of Genetics, Biology and Biochemistry, Torino, Italy,
3Universita` di Torino, Dept Biomedical Sciences and Human Oncology, Torino, Italy
INTRODUCTION. Aberrant wound-healing responses to injury leading to lung fibrosis
contribute to the pathogenesis of ARDS and are associated with high morbidity and mortality.
Lung inflammation and collagen deposition are caused by leukocytes and fibroblasts
migrating into fibrin rich exudates. Class IA of the phosphoinositide 3 kinase family are
mainly activated by receptor tyrosine kinases and form heterodimers composed of a catalytic
subunit (p110a, b and d) and an adaptor protein. Previous studies suggested a role of p110b in
platelet aggregation, cellular migration and epithelial mesenchymal transition, which are
involved in the pathogenesis of lung fibrosis. The aim of this study was to investigate the role
of p110b in an animal model of lung injury.
METHODS. Wild type (WT) and kinase dead (KR) mice, expressing a catalytically inactive
form of p110b were used. Lung injury was induced by intratracheal instillation of bleomycin
sulphate (3 UI/kg), while control mice received only saline vehicle instillation. Following
14 days the severity of fibrosis and lung inflammation (Hematoxylin-Eosin and Sirius red),
BALF proteins content, and synthesis of procollagen and fibronectin (RT PCR) were assessed.
Data are expressed as mean ± SEM.
RESULTS. See Table 1. * p \ 0.05 KR bleo vs WT bleo;  KR and WT bleo vs KR and WT




KR saline WT bleo KR bleo
Histological lung fibrosis
(arbitrary units)
1.2 ± 0.2 1.5 ± 0.3 4.8 ± 0.4 6 ± 0.4*,
Procollagen (fold
increase over control)
1 4.2 ± 0.5§ 11.2 ± 1.2 26.5 ± 5.1*,
Fibronectin (fold increase
over control)
1 3.7 ± 0.4§ 13.8 ± 1.8 57 ± 6.6*,




1.2 ± 0.2 1 2.15 ± 0.12 2.78 ± 0.15*,
CONCLUSION. Compared to wild type PI3K b kinase dead mice had more lung fibrosis,
altered vascular permeability and lung inflammation.
We provide the first evidence for the crucial role of PI3K b kinase activity in tissue injury
repair and lung inflammation.
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THE ANGIOPOIETINS HAVE OPPOSING EFFECTS ON THE SENSITIVITY OF
HUMAN PULMONARY MICROVASCULAR ENDOTHELIAL CELLS TO MEDIA-
TOR-INDUCED, BUT NOT TO BASAL PERMEABILITY
M. van der Heijden1,2, G. P. van Nieuw Amerongen2, V. W. van Hinsbergh2,
A. B. Groeneveld1
1VU University Medical Center, Intensive Care, Amsterdam, Netherlands,
2VU University Medical Center, Physiology, Amsterdam, Netherlands
INTRODUCTION. Endothelial activation by host-derived mediators, such as thrombin, is
central in the pathogenesis of pulmonary permeability during acute lung injury (ALI). Novel
mediators that may be involved include the Tie2 receptor ligands angiopoietin-1 (Ang-1) and
angiopoietin-2 (Ang-2), since plasma Ang-2 and the Ang-2/Ang-1 ratio were associated with
pulmonary permeability and severity of ALI in critically ill patients. Experiments in human
pulmonary microvascular endothelial cells (HPMVECs) specifically could further contribute
to elucidate the effects of the angiopoietins on basal and thrombin-induced permeability. We
hypothesised that Ang-1 reduces and Ang-2 enhances permeability.
OBJECTIVES. To study the effect of Ang-1 and Ang-2 on basal and thrombin-induced
permeability of HPMVECs.
METHODS. HPMVECs were isolated from healthy lung obtained after lobectomy for car-
cinoid or metastasis. The phosphorylation status of the Tie2 receptor was analysed by western
blotting. The permeability of the HPMVEC monolayer was assessed by measuring the
transendothelial electrical resistance (TEER). The rate at which the thrombin-induced per-
meability occurred and the maximum thrombin-induced permeability were analysed as
indicators of the stability of cell-cell junctions and cell contractility, respectively.
RESULTS. The angiopoietins had opposing effects on phosphorylation of the Tie2 receptor,
since Ang-1 induced a transient increase in Tie2 phosphorylation (p \ 0.05), which was
prevented by co-treatment with Ang-2 (p \ 0.05). Surprisingly, the angiopoietins did not
affect the basal barrier function of HPMVECs. Interestingly, Ang-1 reduced and Ang-2
enhanced the rate at which the thrombin-induced permeability occurred by 25 ± 11%
(p \ 0.01) and 61 ± 34% (p \ 0.05), respectively, while they had a less pronounced effect
on the maximum thrombin-induced permeability (19 ± 3% reduction by Ang-1, p \ 0.0001
and 18 ± 10% enhancement by Ang-2, p = 0.0874).
CONCLUSIONS. Our data indicate that Ang-1 and Ang-2 do not affect the basal barrier
function of human pulmonary MVECs, while they have opposing effects on the rate at which
the thrombin-induced permeability occurred, more than the maximum thrombin-induced
permeability. The latter suggests that angiopoietins modulate the stability of the junctions
before and during thrombin-stimulation, rather than the thrombin-induced cell contractility.
GRANT ACKNOWLEDGEMENT. Supported by a Grant from the European Society of
Intensive Care Medicine (ECCRN Levi Montalcini Biomedical Sciences Award 2007).
S214 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
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ROLE OF PTX3 IN LEUKOCYTE RECRUITMENT IN ACUTE PHASE IN A
MURINE MODEL OF ACID ASPIRATION LUNG INJURY
V. Zambelli1,2, M. Scanziani1, L. Deban3, F. Moalli3, M. Amigoni1, F. Fumagalli1,2, S. Deab1,
B. Bottazzi3, R. Latini2, A. Mantovani3, A. Pesenti1
1Milano-Bicocca University, Department of Experimental Medicine, Monza, Italy, 2Istituto di
Ricerche Farmacologiche Mario Negri, Cardiovascular Research, Milano, Italy, 3Istituto
Clinico Humanitas, Rozzano, Italy
INTRODUCTION. Pentraxins are a superfamily of acute phase proteins. The prototypic long
pentraxin 3 (PTX3) is rapidly produced and released by various cell types in response to
inflammatory signals. A recent prospective study showed that PTX3 is elevated in ALI and
ARDS and that its levels correlate with parameters of lung injury and systemic involvement.
OBJECTIVES. Our aim was to determine the role of PTX3 in inflammation in a murine
model of ALI in the acute phase.
METHODS. Mice were injected with 100 lg of human PTX3 i.v. (hPTX3 +) or sterile saline
(hPTX3 -), anesthetized and ventilated (Vt 8–10 ml/kg, RR 140 min-1, FiO2 0.21). In order
to induce lung injury 2 ml/kg of HCl (pH = 1.5) was instilled intratracheally. Mice were
ventilated for 10 min, then kept in an oxygenated chamber until full awakening (FiO2 0.5). To
evaluate the severity of injury, animals were sacrificed after 3 h and Broncho-Alveolar
Lavage (BAL) was performed and lungs were removed and stored.
RESULTS. 3 h after acid instillation, pre-treatment with hPTX3 allowed a significant
reduction of total cell recruitment in the alveolar space; in particular, neutrophilic influx in
BAL was significantly reduced compared to mice pretreated with saline. We observed the
same results also in pulmonary tissue.
Fig. 1 [PMN_BAL]
Fig. 1 [PMN_tissue] *p \ 0.05 vs hPTX3-
CONCLUSIONS. In this murine model of acid aspiration pneumonitis we showed a role of
PTX3 in the initial inflammatory process, since the pre-treatment with exogenous human
PTX3 reduced cellular recruitment in alveolar spaces. Thus, PTX3 might act as a intrinsic
fine-regulator of initial inflammatory response, possibly limiting excessive inflammation-
induced tissue damage.
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CRITICAL ROLE OF ADENOSINE RECEPTOR A1 FOR LPS-INDUCED TRAF-
FICKING OF PMNS IN THE LUNG
K.-C. Ngamsri1, R. Wagner1, I. Vollmer1, S. Stark1, J. Reutershan1
1University Hospital Tu¨bingen, Anaesthesiology and Critical Care Medicine, Tu¨bingen,
Germany
INTRODUCTION. Excessive transmigration of PMNs play a major role in the early
development of acute lung injury (ALI). Extracellular adenosine is involved in various
inflammatory pathways by signalling through four subtypes of adenosine receptors, A1, A2A,
A2B, and A3, all members of the family of G protein-coupled receptors. A1 has particularly
been implicated in leukocyte migration to inflamed tissues. However, its role in acute pul-
monary inflammation remains elusive. We therefore sought to characterize the role of A1 in a
model of LPS-induced migration of PMNs into the lung.
MATERIALS AND METHODS. In a murine model of acute lung injury, C57/Bl6 and for
A1 gene deficient mice (A1-/-) were exposed to aerosolized LPS. We used a flow cytometry-
based method to quantify the accumulation of PMNs in all compartments of the lung. LPS-
induced microvascular permeability was determined by the extravasation of Evans blue, and
the release of inflammatory cytokines into the brochoalveolar lavage fluid (BAL) was
assessed by ELISA. In addition, we tested the effects of the selective A1 agonist 20-Me-CCPA
in vitro and in vivo. To determine specific effects of A1 on hematopoietic and non-hema-
topoietic cells, chimeric mice were generated by transfer of bone marrow between wildtype
and A1-/- mice.
RESULTS. LPS inhalation resulted in significant accumulation of PMNs in all compartments
of wildtype mice. PMN recruitment into interstitium and alveolar airspace of A1 gene defi-
cient mice was significantly higher than in wildtype mice. Pharmacological activation of A1
significantly reduced PMN migration to interstitium and alveolar airspace of wildtype but not
of A1-/- mice. In chimeric mice that express A1 only on hematopoietic cells, PMN migration
into the interstitium was significantly higher than in chimeric mice that expressed A1 only on
non-hematopoeitic cells. Pharmacological activation of A1 in chimeric mice did only reduce
PMN migration when A1 was expressed on hematopoietic cells. LPS-induced increase in
Evans blue leakage was significantly higher in A1-/- compared with wild-type mice. Con-
sistent with these results, the activation of A1 resulted in a significant decrease of
microvascular permeability in wildtype mice. Pretreatment with the specific A1 agonist
(1 mg/kgKG, ip.) decreased the release of the chemokines MIP-2 and TNFa into the alveolar
space. In addition, pharmacological activation of A1 adenosine receptor resulted in significant
decrease of the migration of human PMNs in an in vitro transmigration assay.
CONCLUSION. A1 plays a critical role in LPS-induced PMN transmigration and micro-
vascular permeability in a murine model of ALI. These protective effects appear to be
mediated by A1 on hematopoietic cells. Activation of A1 reduces PMN trafficking during
pulmonary inflammation and maybe a promising approach to develop innovate therapeutic
strategies for the treatment of ALI.
Early diagnosis and epidemiology of AKI: 0832–0836
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NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN ACUTE
KIDNEY INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS
M. Haase1, R. Bellomo2, P. Devarajan3, A. Haase-Fielitz1, NGAL Meta-Analysis Investigator
Group
1Charite´-Universita¨tsmedizin Berlin, Campus Virchow-Klinikum, Dept of Nephrology and
Intensive Care Medicine, Berlin, Germany, 2Austin Hospital, Dept of Intensive Care, Mel-
bourne, Australia, 3Cincinnati Children’s Hospital Medical Center, Dept of Pediatrics and
Developmental Biology, Cincinnati, United States
INTRODUCTION. Neutrophil Gelatinase-Associated Lipocalin (NGAL) appears to be a
promising biomarker for the early diagnosis of acute kidney injury (AKI), however a wide
range in its predictive value has been reported.
OBJECTIVES. To perform a systematic review and meta-analysis of all observational
studies to determine the diagnostic and prognostic performance of NGAL and to identify
potential confounders or effective modifiers of its value in AKI.
METHODS. We searched MEDLINE, EMBASE, CENTRAL databases and congress
abstracts for studies that reported the value of NGAL to predict AKI in different clinical
settings. We included observational cohort studies using custom-made standardized data-
sheets sent to the authors. The primary outcome was AKI defined as creatinine increase[50%
from baseline within 7 days. Secondary outcomes included renal replacement therapy (RRT)
initiation and in-hospital mortality.
RESULTS. We analyzed data from 18 studies and 7 countries involving 2,488 patients, out
of whom 452 (18.2%) developed AKI. Overall, the area-under-the-curve for the receiver-
operating-characteristic (AUC-ROC) of NGAL to predict AKI was 0.812 (95% CI 0.729–
0.889, I2 = 44.5% for heterogeneity). We found a [0.1 AUC-ROC unit difference in favor
of standardized platforms (AUC-ROC 0.830, I2 = 7.0%) with cut-off of [150 ng/ml
compared to ‘research-based’ ELISA’s (0.729, I2 = 32.6%). In cardiac surgery patients, the
AUC-ROC of NGAL was 0.771, I2 = 28.8%, in critically ill patients 0.728, I2 = 17.5%
and after contrast infusion 0.894, I2 = 3.2%. The diagnostic value of plasma/serum NGAL
(AUC-ROC 0.771, I2 = 21.2%) was similar to that of urine NGAL (AUC-ROC 0.836,
I2 = 22.9%), p = 0.72. We identified age to be an effective modifier of NGAL value with
better predictive ability in children (AUC-ROC 0.930, I2 = 3.5%) compared to adults
(AUC-ROC 0.780, I2 = 28.5%); p = 0.036. NGAL was a useful prognostic tool with
regard to the prediction of RRT initiation (AUC-ROC 0.782, I2 = 9.5%) and in-hospital
mortality (AUC-ROC 0.706, I2 = 10.3%).
CONCLUSIONS. NGAL is of diagnostic and prognostic value for AKI and may be con-
sidered as a useful early identifier of patients at risk for randomized controlled trials of
preventive and therapeutic interventions in AKI.
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CHANGE OF PLASMA CREATININE CONCENTRATION DURING THE 6 FIRST
HOURS AFTER ADMISSION TO THE INTENSIVE CARE UNIT (ICU) ALLOWS
EARLY PREDICTION OF SUBSEQUENT ACUTE RENAL FAILURE
M. Skarzynski1, D. Garot1, E. Mercier1, A. Legras1, P. F. Dequin1, D. Perrotin1, S. Ehrmann1
1CHRU Tours, Service de Re´animation Me´dicale Polyvalente, Tours, France
INTRODUCTION. Increasing creatinine plasma concentrations are usually associated with
worsening renal function. Nevertheless this supposes a constant creatinine production and
distribution volume. Whereas the former may be considered true over a short time period, the
volume of distribution is subject to important changes at the initial phase of resuscitation,
mainly because of fluid loading. Therefore an increase of creatinine plasma concentration
may not only reflect changes in renal function in this context.
OBJECTIVES. To evaluate if change of plasma creatinine concentration (D creatinine)
corrected for concomitant changes in its distribution volume over the first 6 h after ICU
admission could predict a subsequent worsening of acute kidney injury (AKI).
METHODS. Observational, prospective study in a 25-bed medical adult ICU. Inclusion
criteria were: urinary catheterization and at least one of the following within 2 h of
admission: systolic blood pressure B90 mmHg; mean arterial pressure B65 mmHg; fluid
resuscitation greater than 1,000 ml; use of vasopressors. Exclusion criteria were dialysis
before inclusion and kidney transplantation. AKI was evaluated according to the RIFLE
classification. Prospectively collected data were used at H0 (time of admission), H6, H24
and Day 3 to Day 7. Worsening of AKI after H6 was defined as an increase in RIFLE
classes (NoAKI \ Risk \ Injury \ Failure) at any time during the study period after H6.
D creatinine was evaluated uncorrected (Equation 1: [C]H6/[C]H0) and corrected for changes
in creatinine distribution volume and hemodilution (Eqs. 2 and 3 respectively).
Equation 2: [[C]H6 9 0.6 9 (W+ fluid balance)]/[[C]H0 9 0.6 W].
Equation 3: ([C]H6/[C]H0)/(HbH6/HbH0).
[C]H6 and [C]H0 stand for plasma creatinine concentration at H6 and H0, W for body weight;
HbH6 and HbH0 for haemoglobin concentration at H6 and H0, fluid balance for difference
between fluid input and output between H0 and H6.
RESULTS. 49 patients were included (median [25th; 75th percentile) age 62 [49; 74] years,
SAPS II 41 [30; 53,]). 27 patients (55%) had worsening of AKI after H6. There was no
significant difference of uncorrected D creatinine between patients with or without worsening
AKI after H6 (0.93 [0.89; 0.98] vs 0.85 [0.81; 0.95]). When correcting D creatinine using
Eqs. 2 or 3, patients with subsequent worsening AKI had a significantly higher corrected D
creatinine (0.99 [0.94; 1.04] vs 0.90 [0.85; 0.99] p = 0.02 and 1.00 [0.90; 1.06] vs 0.89 [0.81;
0.93] p \ 0.01 for Eqs. 2 and 3 respectively).
CONCLUSIONS. When correcting for resuscitation induced changes in distribution volume,
small changes in plasma creatinine concentrations occurring over the first 6 h in the ICU may
allow identifying patients at risk of subsequent worsening AKI.
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NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS AN EARLY BIO-
MARKER FOR ACUTE KIDNEY INJURY IN AN ADULT ICU POPULATION
D. Cruz1, M. de Cal1, F. Garzotto1, S. Gramaticopolo2, P. Piccinni2, C. Ronco1
1San Bortolo Hospital, Nefrology, Vicenza, Italy, 2San Bortolo Hospital, Anesthesia and
Intensive Care, Vicenza, Italy
INTRODUCTION. Serum creatinine is a late marker of acute kidney injury (AKI), hindering
timely intervention. Plasma and urine NGAL have been shown to be useful early markers for
AKI when the timing of the renal insult is known, such as post-cardiac surgery and radio-
contrast nephropathy [1]. In children, NGAL both in urine and plasma is an excellent early
marker of AKI with an area under the receiver operator characteristic curve (AuROC) in the
range of 0.8–0.9 [2]. However, its performance in a general adult medical-surgical ICU
setting has not yet been well described.
OBJECTIVES. The study aims at evaluating the usefulness of plasma NGAL as an early
marker of AKI in an adult general ICU.
METHOD. This was a prospective cohort study of 307 consecutive incident patients to an
adult ICU, enrolled within 24 h of ICU admission. We excluded 5 patients with ESRD,
leaving 302 patients for analysis. Clinical data, including urine output and serum creatinine,
were collected daily up to ICU discharge. Blood samples for NGAL were collected daily from
ICU admission for up to 4 days. Plasma NGAL (pNGAL) was measured in 873 blood samples
(median 3 samples/patient), using a point-of-care device (Triage NGAL, Biosite Inc, San
Diego, CA).
AKI was defined using the RIFLE (Risk-Injury-Failure-Loss-Endstage renal disease) clas-
sification. RIFLEinitial refers to the patient0s RIFLE class on the 1st day of AKI.
Diagnostic characteristics of pNGAL were evaluated with receiver operating characteristic
(ROC) curves. We defined an event as AKI occurring within 48 h of the first pNGAL
measurement.
RESULTS. Of 302 patients, 133 (44%) developed AKI during their ICU stay. In the AKI
group, 90 patients (29.8%) had AKI within 24 h of ICU admission while 43 (14.2%)
developed it later during their ICU stay (range, 2nd to 45th ICU day). RIFLEinitial class was
Risk in 92 patients (30.5%), Injury in 17 (5.6%) and Failure in 24 (7.9%). Fifteen patients
(5%) were treated with renal replacement therapy for AKI in the ICU.
Plasma NGAL was a good diagnostic marker for AKI development within the next 48 h
(Fig. 1, area under ROC 0.78, 95% CI 0.65–0.90). Using a cut-off of 150 ng/ml for pNGAL,
the sensitivity was 73% and specificity was 81%.
CONCLUSIONS. Plasma NGAL appears to be a useful early marker for the development of
AKI in a heterogenous adult ICU population, in which the timing of the renal insult is largely
unknown. Plasma NGAL allows the diagnosis of AKI up to 48 h prior to a rise in serum
creatinine. It is worth noting, however, that the area under ROC is slightly lower than that
reported in several pediatric studies.
REFERENCES. 1. Ronco C (2007) N-GAL: diagnosing AKI as soon as possible. Critcal
Care 11:173.
2. Zappitelli M et al (2007) Urine N-GALis an early marker of acute kidney injury in critically
ill children: a prospective cohort study. Crit Care 11:R84
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DIAGNOSTIC PERFORMANCE OF FRACTIONAL EXCRETION OF UREA IN
THE EVALUATION OF CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY
INJURY: A MULTICENTER COHORT STUDY
M. Darmon1, F. Vincent2, J. Dellamonica3, F. Schortgen4, F. Gonzalez2, V. Das1, G. Ber-
nardin3, L. Brochard4, Y. Cohen2, B. Schlemmer1
1Saint-Louis University Hospital, Paris, France, 2Avicenne University Hospital, Bobigny,
France, 3Nice University Hospital, Nice, France, 4Henri Mondor University Hospital, Creteil,
France
INTRODUCTION. Several factors including diuretic use and sepsis interfere with the
fractional excretion of sodium (FeNa), which is used to distinguish prerenal from intrinsic
acute kidney injury (AKI). These factors do not affect the fractional excretion of urea
(FeUrea) [1]. However, data on the diagnostic accuracy of FeUrea are conflicting and this
index has never been validated in critically-ill patients.
METHODS. Observational prospective multicenter study performed in three intensive care
units in university hospitals. Consecutive patients, except those with obstructive AKI,
admitted to the participating ICUs during a 6-month period were included in this study. AKI
was defined accordingly to the AKIN definition [2]. Prerenal AKI was defined as AKI with a
cause for renal hypoperfusion and reversal within 3 days. Results are reported as medians
[IQR].
RESULTS. 203 patients aged of 61 years [46–73] were included. Median LOD and SAPSII
score at ICU admission was of respectively 6 [4–9] and 46 [34–60]. According to our
definitions, 67 had no AKI, 54 had pre-renal AKI, and 82 had intrinsic AKI. FeUrea was 39%
[28–40%] in the no-AKI group, 41% [29–54%] in the prerenal AKI group, and 32% [22–
51%] in the intrinsic-AKI group (p = 0.12). FeUrea was of little help for distinguishing
prerenal from intrinsic AKI, the area under the ROC curve being 0.59 (95% confidence
interval, 0.49–0.70; p = 0.06). Sensitivity was 63% and specificity was 54% with a cutoff of
35%. In the subgroup of patients receiving diuretics (n = 63), performance of FeUrea were
similar (AUC ROC Curve 0.58 [0.41–0.75]).
Of the usual urinary indices, performance was best for the urine/plasma urea ratio (ROC curve
AUC, 0.71 [0.62–0.80]). This translates at optimal cut-off (urine/plasma urea ratio less than
12) into a 66% sensitivity and 66% specificity to detect an intrinsic AKI (positive LH, 1.94;
and negative LH, 0.52).
CONCLUSION. FeUrea may be of little help for separating prerenal from intrinsic AKI in
critically ill patients, including those on diuretic therapy. Additional studies are needed to
evaluate alternative markers or strategies for differentiating prerenal from intrinsic AKI.
REFERENCES. 1. Bagshaw S et al (2007) Intensive Care Med 33:1285–1296
2. Bellomo R et al (2001) Intensive Care Med 27:1685–1688
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THE EPIDEMIOLOGY OF CONTRAST- INDUCED ACUTE KIDNEY INJURY IN
ICU PATIENTS
S. Doom1, L. Delrue1, C. Danneels1, J. Decruyenaere1, E. Hoste1
1Dept of Intensive Care Medicine, University Hospital, Ghent, Belgium
INTRODUCTION. Contrast-induced acute kidney injury (CI-AKI) accounts for more than
10% of hospital-acquired AKI and is associated with increased mortality. Diagnostic and
interventional procedures with radiocontrast are common in Intensive Care Unit (ICU)
patients. Nevertheless, there are little data about the epidemiology of CI-AKI in this group of
high risk patients.
OBJECTIVES. The aim of this study was to examine the incidence of CI-AKI in ICU
patients. We also examined risk factors for CI-AKI and outcomes such as treatment with renal
replacement therapy (RRT) within 1 w after contrast, length of stay (LOS) in the ICU, and
ICU mortality rate.
METHODS. We performed a single-centre, retrospective study in our 56 bed tertiary care
ICU. Data were collected from the computerized ICU database during the period 18-03-2004
until 31-12-2008. We included patients who received intravascular iodated radiocontrast
during a computed tomography (CT) or a non-coronary angiography procedure during ICU
stay. Only the first procedure was evaluated. Patients who had another procedure within
3 days after the first were excluded. We also excluded patients who were treated with RRT at
time of procedure. CI-AKI was defined as an increase in serum creatinine (Cr) of C25% or an
increase of C0.5 mg/dl within 3 days after contrast administration. Contrast media were non-
ionic and iso- or low-osmolar.
RESULTS. We identified 1,421 ICU patients who underwent a CT with contrast or an
angiography. Of these, 619 were excluded, resulting in a study population of 802 patients. CI-
AKI occurred in 133 patients (16.6%). These patients were older (65 year vs. 59, p = 0.004),
more severely ill, as illustrated by a higher APACHE II score (20 vs. 17, p \ 0.001), worse
kidney function at baseline (Cr = 1.17 mg/dl vs. 0.78, p \ 0.001; lower 24 h urine output
1.4 l vs. 2.2, p \ 0.001), lower blood pressure (MAP = 65 mmHg vs. 72, p \ 0.001), a more
positive fluid balance preceding contrast (2.3 L vs. 1.1, p \ 0.001), more often on vasoactive
therapy (51.1% vs. 31.1%, p \ 0.001) and required mechanical ventilation more frequently
(63.9% vs. 50.7%, p = 0.005). They had more risk factors for development of CI-AKI:
drug treatment with diuretics, aminoglycosides, ACEI’s, ARB’s or NSAID’s (43.6% vs.
30.5%, p = 0.003), and natriuresis \ 20 mmol/l (24.8% vs. 13.3%, p = 0.001). The inci-
dence of CI-AKI was comparable in patients who underwent an angiography and a CT (both
16.6%). The incidence of RRT treatment was higher (13.5% vs. 4.2%, p \ 0.001) in CI-AKI
patients; they also had a longer LOS-ICU (17d vs. 11, p \ 0.001), and higher ICU mortality
(35.3% vs. 11.5%, p \ 0.001). Also after correction for covariates CI-AKI had a strong
association with ICU mortality (OR = 3.1, 95% CI = 1.9, 5.1, p \ 0.001).
CONCLUSIONS. CI-AKI occurred in 1 out of 8 ICU patients and was associated with worse
outcomes such as need for RRT, and mortality. CI-AKI was a strong predictor for ICU
mortality, even after correction for other covariates.
GRANT ACKNOWLEDGEMENT. None.
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CORRELATION BETWEEN LUNG SOUND HOMOGENEITY INDEX AND STATIC
COMPLIANCE: PRELIMINARY FINDINGS
S. Lev1, M. Shapiro2, J. Cohen2, Y. Glickman3, P. Singer1
1Rabin Medical Center, Beilinson Hospital, Petach Tiqva, Israel, 2RMC, Petach Tiqva, Israel,
3Deep Breeze, Ltd., Or-Akiva, Israel
INTRODUCTION. Increased homogeneity of lung sound distribution has been correlated
with improved Functional Residual Capacity (FRC) in mechanically ventilated ICU patients.
In the present study, we correlate lung sound distribution homogeneity index (HI) with static
compliance (Cs).
OBJECTIVES. To assess the relationship between lung sound distribution and compliance.
METHODS. Thirty-two lung sound measurements were performed with the VRI system in 13
ICU mechanically ventilated patients with lung injury. Patients were recorded at different levels
of PEEP before and after recruitment maneuver and Cs was obtained from the ventilator at each
data point. HI (range 0–100%) was computed based on the distribution of lung sounds in 4 lung
segments at peak inspiration. Cs were compared between two groups (group 1: HI B 80% and
group 2: HI [ 80). p-Values were obtained using the Wilcoxon Two Sample Test.
RESULTS. Significantly lower static compliance was detected for the group with lower
homogeneity index than for the group with higher homogeneity index (31 ml/mbar versus
43 ml/mbar, p = 0.05).
Fig. 1 Homogeneity index vs static compliance
CONCLUSION. Homogeneity of lung sound distribution decreases with decreased lung
compliance.
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NEW ANTICOAGULATION METHOD WITH SELECTIVE IN-CIRCUIT BLOOD
COOLING FOR CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT): THE
EFFECT ON PLATELET AND LEUKOCYTE FUNCTION
A. Krouzecky1, J. Chvojka1, R. Sykora1, J. Radej1, I. Novak1, J. Ruzicka2, J. Benes2,
Z. Petrankova2, J. Hanzlikova3, L. Bultasova4, M. Matejovic1
1Charles University Medical School and Teaching Hospital, ICU, 1st Medical Dept., Plzen,
Czech Republic, 2Charles University Medical School, Dept. of Biophysics, Plzen, Czech
Republic, 3Charles University Medical School and Teaching Hospital, Institute of Immu-
nology and Allergology, Plzen, Czech Republic, 4Charles University Medical School and
Teaching Hospital, Institute of Clinical Biochemistry and Hematology, Plzen, Czech Republic
INTRODUCTION. We have recently shown that a selective in-circuit blood cooling (to
20C) is effective alternative strategy for anticoagulation during 6 h hemofiltration. To further
test its safety we investigated the effects of long-term procedure on functional properties of
platelets and leukocytes.
METHODS. 13 anesthetized and ventilated pigs were randomized to receive continuous
hemofiltration (CVVH) with anticoagulation secured either with selective cooling of extra-
corporeal circuit (ECC) (COOL; n = 8) or with standard systemic heparinization (HEPARIN;
n = 5). Before the procedure (T0) as well as 1, 6 and 24 h after starting the hemofiltration
following variables were assessed: 1) agregability of platelets (area under aggregation cur-
ve = AUC; velocity of aggregation = VEL); 2) blastic transformation of T-lymphocytes
(DNA analysis = DNA) and 3) leukocyte oxidative burst (Bursttest = BURST).
RESULTS. Data are median and interquartile range. The median duration of procedure in
COOL group was 17 h (6;22), the patency of all circuits treated with systemic heparinization
was maintained within the predetermined study period (24 h).
TABLE 1 FUNCTIONAL PROPERTIES OF PLATELETS AND LEUKOCYTES
Variable Group T0 T1 T6 T24
AUC (AU) COOL 18.5 (17; 22) 18 (15.5; 19) 14 (9; 17) 12 (6; 15.8)





COOL 5.9 (5.4; 6.1) 5.3 (4.8; 5.5) 5 (4.3; 5.3) 4.4 (3; 5.2)
HEPARIN 6.1 (4.8; 6.8) 4.4 (4; 5.1) 4.2 (3.7; 7.1) 5 (4.1; 5.6)






HEPARIN 38 (29;42) 37 (32;46) – 43 (33;47)
BURST (%) COOL 98 (96;99) 99 (96;100) – 99 (97;100)
HEPARIN 98 (86;100) 99 (92;100) – 99 (98;100)
CONCLUSION. The method of selective in-circuit blood seems to be effective in main-
taining ECC patency for several hours without adversely affecting functional properties of
leukocytes and platelets.
GRANT ACKNOWLEDGEMENT. MSM 0021620819 Replacement of and support to
some vital organs.
REFERENCE. Krouzecky et al (2009) Intensive Care Med 35:364–370
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FONDAPARINUX VS LOW MOLECULAR WEIGHT HEPARIN AS A THROMBO-
PROPHYLAXIS IN CRITICALLY ILL PATIENTS. COAGULATION STATUS
MONITORED BY THROMBOELASTOGRAPHY (TEG)
G. Mineo1, N. D. Cascio1, D. Canzio1, L. Marino1, G. Evangelico1, A. Cortegiani1,
S. M. Raineri1
1University of Palermo, Anesthesiology and Intensive Care, Palermo, Italy
INTRODUCTION. The rationale for use of thromboprophylaxis is based on solid principles
and scientific evidence. Almost all hospitalized patients have at least one risk factor for VTE,
and approximately 40% have three or more risk factors Without thromboprophylaxis, the
incidence of objectively confirmed, hospital-acquired DVT is approximately 10–40% among
medical or general surgical patients and 40–60% following major orthopedic surgery.
Thromboprophylaxis with unfractionated heparin (UF) or low molecular weight heparins
(LMWHs), UTI is often associated to thrombocytopenia, poorly tolerated in critically ill
patients. The Fondaparinux (F) is the first of a new class of antithrombotic drugs that
selectively inhibits factor Xa, has no direct effect on IIa and it is not associated with a
thrombocytopenia. The aim of this study was to monitoring the coagulation status of critically
ill patients undergoing therapy with F and LMWH by the thromboelastography (TEG).
METHODS. We enrolled 32 patients with COPD, and APACHE II [25. 16 treated with F
(2.5 mg/day) (Group F) and 16 with LMWH (Group H). In these patients TEG was performed at the
admission and twice daily during hospitalization. Were evaluated the average r, k, MA, and Ly 30.
RESULTS. Groups were homogeneous for age, sex and APACHE II. The differences in average
time to TEG have shown non-significant in both groups of patients regarding r, k and Ly30. While
we found a progressive reduction of MA patients in group H than in group F which is significant in
10th day (Table 1). No thromboembolic or hemorrhagic complication was recorded.
TABLE 1 TEG PARAMETERS AND PLATELET COUNTS
Group F Group H
T0 T5 T10 T0 T5 T10
r (min) 4.9 (1.9) 5.1 (1.6) 6.9 (0.9) 5.3 (1.6) 5.5 (1.6) 6.1 (1.2)
MA (mm) 62 (15) 67 (10) 61 (13)* 63 (12) 54 (15) 29 (13)*
Ly30 (%) 3.6 (1.2) 4.4 (1.2) 4.1 (1.4) 4.3 (0.3) 3.9 (1.6) 4.4 (1.5)
PTL (*10.000) 161 (41) 153 (41) 140 (26) 159 (53) 141 (58) 134 (62)
*p \ 0.05
CONCLUSION. F and LMWH were equally safe. Monitoring by TEG showed a significant
reduction in platelet function in Group H than in group F but not in platelet counts. These
results suggest that prophylaxis with F is as effective and safer than LMWH in critically ill
patients and monitoring dynamic coagulation by TEG is a useful method to evaluate the
appropriateness and the timing of invasive procedures.
REFERENCE. 1. Cohen AT, Davidson BL, Gallus AS et al (2006) Efficacy and safety of
fondaparinux for the prevention of venous thromboembolism in older acute medical patients:
randomised placebo controlled trial. BJM 332(7537):325–329
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THE EFFECT OF PROMETHEUS DEVICE ON LABORATORY MARKERS OF
INFLAMMATION AND TISSUE REGENERATION IN ACUTE LIVER FAILURE
MANAGEMENT
M. Rocen1, E. Kieslichova1, D. Merta1, E. Uchytilova1, Y. Pavlova1, P. Trunecka1
1IKEM, Prague, Czech Republic
INTRODUCTION. Prometheus based on modified FPSA (Fractionated Plasma Separation
and Adsorption) method is used in therapy of acute liver failure as a bridge to liver trans-
plantation. Clinical features of acute liver failure are similar to septic shock as well as the
dynamics of inflammatory markers level. We suppose, that the therapeutic effect of Prome-
theus treatment for patients with liver failure is caused not only by the elimination of
terminal metabolites (urea, creatinine, ammonia, bilirubin). The aim of the study was to
identify the impact of treatment on the levels of released cytokines and markers of inflam-
mation and liver regeneration.
METHODS. From VII/06 till XI/08, 11 consecutive patients on the waiting list for liver
transplantation with acute liver failure were investigated. These patients underwent 26 ther-
apeutic courses on Prometheus device. Before and after each treatment blood samples were
drawn and processed by Elisa method on Luminex equipment, the plasma levels of IL-1a, IL-
6, IL-8, IL-10, IL-12, TNFa, HGF and a1 fetoprotein were surveyed. PCT was determined by
the immunoluminometric assay. Patients were observed and treated conservatively according
to their clinical status until transplantation. All data were prospectively recorded to the
protocol. Statistic processing: we evaluated the kinetics of cytokines plasmatic concentrations
during each treatment procedure by the method of pair t-tests and nonparametrics by Mann–
Whitney tests.
RESULTS. The experimental group consists of 3 males and 8 females, of average age
39.6 ± 12.1 years. Hepatic impairment at the time of FPSA treatment indication was
according to Child-Pugh score 12.8 points ± 0.7 (C) and SOFA score 12.6 ± 5.6 before each
treatment. Total of 26 courses of FPSA were undertaken (1–8 per patient), on every other day.
In the samples drawn prior to the therapy, there were detected elevated levels of IL-6, IL-8,IL-
10, TNFa, CRP and PCT. The level of TNFa decreased significantly (p \ 0.05) during the
therapy, the decrease of CRP and PCT was significant (p \ 0.01), (p \ 0.05) as well. The
level of a1 fetoprotein (p \ 0.01) also declined significantly during FPSA elimination. Sur-
prisingly an increase of HGF (p \ 0.05) was detected. The decline in concentrations of IL-6,
IL-8, IL-10 was not significant. Serum concentrations of IL-1a and IL-12 were not elevated.
CONCLUSIONS. Our results show that Prometheus is effective in the clearance of
inflammatory mediators responsible for SIRS, and that Prometheus therapy affects the serum
levels of inflammatory and regeneration markers important for therapeutic approach in acute
liver failure.
GRANT ACKNOWLEDGEMENT. Supported by the Research project IGA NR/9405-3 of
the Czech Ministry of Health.
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CELL DEATH IN ACUTE HEPATIC FAILURE AND MARS TREATMENT
B. A. Lubsczyk1, G. Roth1, J. Pilz1, P. Faybik1, H. Hetz1, A. Bacher1, C. Krenn1
1Medical University of Vienna, General Hospital, Dept. of Anaesthesia and Intensive Care
Medicine, Vienna, Austria
INTRODUCTION. Apoptosis and necrosis from hepatocytes are a hallmark of acute hepatic
failure. Caspase cleaved cytokeratin 18 (CK18) has been recently identified as a novel
apoptosis serum marker for epithelial cells, whereas total CK18 is released when cells
undergo necrosis. Serum nucleosomes have been also successfully used as a marker for cell
death in a variety of cell types and disease states. Apoptosis from leukocytes as well as
hepatocytes has been recently linked to the immune dysfunction seen in patients suffering
from acute hepatic failure. Artificial liver assist devices like the molecular adsorbent recir-
culating system (MARS) have been introduced in clinical practice to support organ function
or to bridge to liver transplantation.
OBJECTIVES. We sought to investigate, if there are differences regarding apoptosis and
necrosis in acute liver failure (ALF) or acute on chronic liver failure (ACLF).Further we
studied the effect of the MARS on this cell death markers, since triggering of apoptosis or
necrosis by the extracorporeal blood circuit of MARS could have deleterious effects in ALF
and ACLF, and mitigate beneficial effects of the MARS treatment.
METHODS. Serum concentrations of cleaved CK18, total CK18 and nucleosome levels were
determined by a commercially available ELISA kits in ten ALF and ten ACLF patients
undergoing MARS immediately before and after the first treatment cycle. Indications for
MARS therapy were ammonia levels of 100 lmol/l or higher with hepatic encephalopathy
grade 3, eligibility for liver transplantation. 12 patients with chronic hepatic failure (CHF)
with Child-Pugh-Score C, who were clinically stable as well as 14 healthy individuals served
controls. Data are given as median with range.
RESULTS. Baseline cleaved CK-18 serum concentrations were significantly increased in
ALF and ACLF patients as compared to the healthy controls (p \ 0.002 for both). Cleaved
CK18 was significantly increased in CHF compared to the healthy controls (p \ 0.01).
Differences between the ALF, ACLF and CHF group did not reach statistical significance.
Results for total CK18 were similar. Baseline nucleosome serum concentrations were sig-
nificantly increased in ALF and ACLF patients as compared to CHF and healthy controls.
Between the ALF and ACLF group there was no statistically significant difference. MARS
had no obvious effect on the cleaved CK18, total CK18 and nucleosome serum concentra-
tions. In both populations, ALF as well as the ACLF, serum concentrations remained constant
CONCLUSIONS. Serum nucleosome levels maybe useful to discern acute from chronic
hepatic failure or to monitor the course and the severity of the disease. MARS therapy
apparently did not stimulate the production of these cell death related molecules in our patient
collective after one treatment cycle, providing no evidence of deleterious effects through
increased cell death triggered by MARS.
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IMPACT OF ORAL DECONTAMINATION WITH CHLORHEXIDINE 1% GEL ON
COLONISATION OF THE RESPIRATORY TRACT IN VENTILATED PATIENTS
IN A GENERAL ICU
R. J. H. Jackson1, F. E. Kelly1, W. English1, J. Gatward1, T. Gould1
1Bristol Royal Infirmary, Intensive Care Unit, Bristol, United Kingdom
INTRODUCTION. Ventilator associated pneumonia (VAP) is common in critically ill
patients, and is associated with increased mortality. Aspiration of bacteria from the oro-
pharynx is thought to be important in the pathogenesis of the condition. Consequently,
selective digestive tract decontamination has been used to reduce the oral bacterial load in an
attempt to reduce the incidence of VAP, although the efficacy of this remains unclear [1, 2].
Concerns regarding increased selection of antibiotic-resistant bacteria have resulted in a
search for alternative strategies to reduce airway contamination. Topical application of the
antiseptic chlorhexidine gluconate (CHX) has achieved varying results, however, the con-
centration and formulation has varied between studies. In cardiac surgical patients at low risk
of VAP, CHX 0.12% was effective at reducing VAP [3]. In medical and mixed ICU popu-
lations, CHX 0.12% was found to be ineffective in most trials although CHX 2% did show a
reduction in VAP [4]. CHX 2% is not available in the UK. CHX 1% gel is used by our oral
surgery department, so we introduced this to our ICU and audited the results.
OBJECTIVES. To assess the impact of routine oral CHX 1% gel application on culture rates
from bronchoalveolar lavage (BAL) and protected catheter (PC) screening performed on
ventilated patients in a 14-bed medical and surgical ICU in a University Hospital.
METHODS. Permission was obtained from our clinical audit department. Data were col-
lected retrospectively for all BAL and PC samples for two consecutive 6-month periods:
before and after the implementation of routine CHX oral decontamination (in January 2008).
PC samples were collected routinely for screening on a twice weekly basis, and BAL was
performed when clinically indicated. PC samples were considered positive if [104 colony
forming units (CFU) were present; BAL if [105 CFU were present. Where a sample grew
multiple organisms, this was considered as a single positive result.
RESULTS. Prior to CHX use, 154 samples (20 BAL, 134 PC) were collected. Of these 24
(15.6%, 3 BAL, 21 PC) were positive. Following commencement of routine CHX use, 225
samples (71 BAL, 154 PC) were collected. Of these, 19 (8.4%, 4 BAL, 15 PC) were positive.
The reduction in positive results was statistically significant (2-sided Fisher’s exact test,
p = 0.047). CHX appeared to exhibit greatest impact on gram-negative organisms (23
positive cultures pre-CHX, 13 post-CHX), whilst having the opposite effect upon fungi (3
positive cultures pre-CHX, 6 post-CHX).
CONCLUSIONS. In this small retrospective study, a reduction in the rate of microbiological
contamination of the lower respiratory tract was observed following the introduction of
routine oral decontamination with CHX 1% gel in invasively ventilated patients. No adverse
incidents involving CHX were reported during the study period.
REFERENCES. 1. de Smet NEJM Jan 09
2. Chan BMJ 2007
3. Deriso AJ Chest 1996
4. Koeman Am J Respir Crit Care Med 2006
GRANTS. None.
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ANTIBIOTIC PRESCRIBING HABITS IN A TERTIARY REFERRAL INTENSIVE
CARE UNIT
D. Trainor1, S. Gallagher1, L. James1, P. Glover1
1The Regional Intensive Care Unit, The Royal Victoria Hospital, Belfast, United Kingdom
INTRODUCTION. More than 75% of patients admitted to the intensive care unit (ICU)
receive at least one antibiotic during their stay [1]. In patients suffering from severe sepsis and
septic shock prompt antimicrobial therapy saves lives [2]. However, it has been recognised
that excessive and inappropriate use of antibiotics is associated with the emergence of
multidrug resistant bacteria [3].
OBJECTIVES. We carried out a prospective observational study of antibiotic prescribing
habits in 30 consecutive patients admitted to a tertiary referral mixed medical-surgical adult
ICU.
METHODS. We examined antibiotic prescriptions prior to ICU admission, prescriptions
initiated in ICU, whether prescriptions were empirical or targeted against identified organ-
isms, and duration of antibiotic prescribing. Microbiological results and the impact this had on
antibiotic prescriptions were also noted.
RESULTS. Twenty-four (80%) patients received at least one antibiotic during their ICU stay
(median length of stay (LOS) 6 days). Six patients (20%) did not receive any antibiotics
whilst in ICU (median LOS 1.5 days). Antibiotics were prescribed prior to ICU admission in
37% of patients, but only 30% of these prescriptions were continued in ICU. Pneumonia was
the commonest indication for antibiotics that were commenced on the ward (87%) and
continued in ICU. 63% of antibiotic administrations commenced in ICU were empirical
(mean duration 3.4 days), 34% targeted (mean duration 9.8 days) and 3% prophylactic (single
dose). Empirical antibiotic prescriptions commenced in ICU were discontinued within 24 h in
33% of cases. Administration of antibiotics occurred within 30 min of the initial prescription
in 55% of cases. No positive microbiological results were obtained in 54% of patients who
received antibiotics in ICU. Staphylococcus aureus was the commonest organism identified in
cases of suspected pneumonia. This was MRSA in 3 out of 4 cases.
CONCLUSIONS. Increasing duration of ICU stay is associated with a greater risk of
receiving antibiotics. Antibiotics are often prescribed in the absence of positive microbio-
logical results. Most patients receiving antibiotics within our ICU initially received empirical
antibiotics, which were administered for a shorter time than targeted antibiotics. It could be
argued that the development of techniques to confirm the presence of bacterial infection may
reduce inappropriate antibiotic administration. These measures may help to decrease the
development of multiresistant bacteria and reduce drug prescribing costs.
REFERENCES. 1. Warren M, Gibb A, Walsh T (2005) J Hospital Infect 59:90–95
2. Dellinger R, Levy M, Carlet J et al (2008) Crit Care Med 36:296–327
3. Yu V, Singh N (2004) Intensive Care Med 30:735–738
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REDUCING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
TRANSMISSION AND BACTERAEMIA IN INTENSIVE CARE: IMPACT OF
UNSELECTIVE DECOLONISATION IN ADDITION TO STANDARD MEASURES
N. T. Tarmey1, A. P. Pallett2, J. M. B. Fennell1
1Southampton General Hospital, General Intensive Care Unit, Southampton, United King-
dom, 2Southampton General Hospital, Microbiology Department, Southampton, United
Kingdom
INTRODUCTION. Methicillin-resistant Staphylococcus aureus (MRSA) is a worldwide
cause of morbidity and mortality in the intensive care unit (ICU) [1]. Current recommen-
dations include active surveillance, improved antibiotic stewardship and the general principles
of infection control [2]. It has also been suggested that unselective decolonisation may be
effective for the control of MRSA propagation when other measures have failed [3]. We
present our experience of reducing MRSA bacteraemia in the ICU by a series of measures,
including unselective decolonisation of all patients admitted to the unit.
OBJECTIVES. To examine the effectiveness of a series of interventions to reduce MRSA
transmission and bacteraemia in the ICU.
METHODS. In April 2005, detailed data collection began for all cases of MRSA in our
institution, a mixed medical and surgical ICU. Between April and December 2005, MRSA
control measures included: active surveillance with isolation of carriers; reduced cephalo-
sporin and fluoroquinolone usage; improved environmental cleaning; hand hygiene and
infection control training for staff; chlorhexidine 4% wash for carriers and contacts. In
February 2006, unselective decolonisation of all patients was begun. All ICU admissions
received chlorhexidine 4% wash, once daily for 5 days and mupirocin 2% nasal ointment,
three times daily for 5 days.
RESULTS. During the first 12 months studied (April 2005–March 2006 inclusive), 51
patients were admitted to ICU colonised with MRSA, 31 patients became MRSA colonised in
ICU and there were 15 cases of MRSA bacteraemia in ICU. During the last 12 months studied
(January 2008–December 2008 inclusive), 74 patients were admitted to ICU colonised with
MRSA (an increase of 45%), 3 patients became MRSA colonised in ICU (a reduction of 90%)
and there was 1 case of MRSA bacteraemia (a reduction of 93%). Mupirocin resistance was
not detected in any samples from ICU during the period studied.
Fig. 1 MRSA in General ICU 2005–2008
CONCLUSIONS. The measures taken were effective in reducing MRSA transmission by
90% and in reducing MRSA bacteraemia by 93% in ICU. This was in spite of an increase in
the number of patients admitted to the ICU colonized with MRSA. Unselective decolonisation
with 4% chlorhexidine washes and nasal mupirocin appears to have contributed significantly
to this effect.
REFERENCES. 1. Eur J Clin Microbiol Infect Dis (2008) 27:409–413
2. J Hosp Infect (2006) 63S:S1–S44
3. J Infect Chemother (2005) 11:231–233
GRANT ACKNOWLEDGEMENT. None
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IDENTIFYING SEPSIS IN TRIAGE: ASSESSMENT OF A NURSE TRIAGE TOOL
C. Cleophax1, S. Bernard2, V. Pasquereau2, M. Celine3, L. Poiree4, N. Simon2
1Poissy Hospital, Intensive Care Unit, Poissy, France, 2Poissy Hospital, Poissy, France,
3Meulan Hospital, Meulan, France, 4Neuilly Hospital, Neuilly sur Seine, France
BACKGROUND. International guidelines highlight the necessity of early identification of
severe sepsis. Triage procedures in the emergency department (ED) represent the first step in
the sepsis chain of survival.
OBJECTIVES. This study assessed a tool intended for the triage nurse to correctly identify
actual or impending severe sepsis.
METHODS. A prospective study was done in three ED, during 2 months. A specific sepsis
triage aid was used for the identification of a possible sepsis syndrome and for risk factors of
impending or obvious severity. The sepsis syndromes were ultimately confirmed and clas-
sified by the emergency physician. Final diagnosis was compared with the initial triage.
RESULTS. Among the 253 patients eventually diagnosed with sepsis, 205 were correctly
identified by the triage nurse. The calculated triage sensitivity was 81% [95% CI: 76–85] for
identification of sepsis and 75% [95% CI: 64–85] for correct prioritization of severe sepsis.
DISCUSSION. Some patients did not present initially with clinical criteria of sepsis and
deteriorated during their stay in the ED. Most of non-suspected patients with sepsis had not
been correctly screened. Furthermore time necessary to apply the screening procedure often
seemed too long in the setting of triage.
CONCLUSION. A simple triage aid for sepsis seems promising. Such a tool must use simple
but relevant criteria and consider the rapid change in clinical state in potentially septic
patients.
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FLUID LEAKAGE PAST TRACHEAL TUBE CUFFS: EFFECT OF SUCTIONING
MANOEUVRE AND TYPE OF CUFF IN A BENCHTOP MODEL
P. Beuret1, M.-J. Carton1, M. Kaaki1, X. Fabre1, J.-C. Ducreux1
1Centre Hospitalier, Intensive Care Unit, Roanne, France
INTRODUCTION. The leakage of oropharyngeal secretions around tracheal tube cuffs is
usually considered as a major risk factor for bacterial tracheal colonization. Tracheal suc-
tioning enhances leakage, by decreasing tracheal pressure. This study aimed to evaluate the
effect of a suctioning manoeuvre without disconnection of the ventilator on leakage,
according to the modalities of suctioning and the type of cuff.
METHODS. A benchtop model of trachea was created using a plastic tubing whose diameter
was in the range of an adult trachea (antero-posterior ID 24 mm, transversal ID 20 mm). The
trachea, angled at 30, was intubated with a size 7.5 mm ID tracheal tube whose proximal end
was connected to a mechanical ventilator—Servo i (Siemens); the distal end of the trachea
was connected to a test lung (Siemens). The ventilator settings were as follows: volume-
control mode, respiratory rate 12 bpm, peak inspiratory pressure at 20 cm H2O, PEEP at
5 cm H2O. The cuff pressure was set at 30 cm H2O. Then, 0.5 ml blue dye followed by 3 ml
saline was instilled just above the cuff. Three types of tubes were tested: Hi-Lo Evac
(Mallinckrodt) with polyvinyl chloride cuff, Microcuff (Kimberly-Clark) and Sealguard
(Mallinckrodt) with polyurethane cuffs. For each type of tube, leakage of dye was evaluated
with each of three sizes of suction catheter (12-14-16 French) and three levels of suction
pressure (-100, -200, -400 cm H2O). Suctioning was performed hourly along 8 h. Each
experiment was performed five times.
RESULTS. Once the cuffs were inflated to a pressure of 30 cm H20 in the model of trachea,
longitudinal folds were observed within the cuff wall of Hi-Lo Evac and Sealguard tubes, but
none for Microcuff. During baseline ventilation with PEEP without suctioning, no leakage
was observed along 8 h with the three types of tube. The incidence of leakage during suc-









Hi-Lo Evac -400 16-14-12 5/5-5/5-1/5
-200 16-14-12 5/5-5/5-0/5
-100 16-14-12 0/5-0/5-0/5
Sealguard -400 16-14-12 1/5-0/5-0/5
-200 16-14-12 1/5-0/5-0/5
-100 16-14-12 0/5-0/5-0/5
Microcuff -400 16-14-12 0/5-0/5-0/5
-200 16-14-12 0/5-0/5-0/5
-100 16-14-12 0/5-0/5-0/5
CONCLUSION. In this model, no leakage of fluid was observed past the three types of tube
tested during 8 h of volume-controlled ventilation with a PEEP level at 5 cm H2O. During
suctioning, when using low levels of negative pressure no leakage was observed with the three
tubes tested. When using high levels of negative pressure, the Microcuff was the sole tube
allowing the use of large size catheters without leakage.
Paediatrics: 0847–0851
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SINGLE NUCLEOTIDE POLYMORPHISMS (SNP’S) IN GENES OF CIRCULA-
TORY HOMEOSTASIS IN SURVIVING PEDIATRIC INTENSIVE CARE PATIENTS
WITH MENINGOCOCCAL INFECTION
H. E. Bunker-Wiersma1, R. P. Koopmans2, T. W. Kuijpers1, H. Knoester1, A. P. Bos1
1Emma Childrens Hospital/AMC, Pediatric Intensive Care Unit, Amsterdam, Netherlands,
2AMC, Clinical Pharmacology and Pharmacotherapeutics, Amsterdam, Netherlands
OBJECTIVE. In the course of a meningococcal infection, invasive and severe disease occurs
in a restricted number of individuals. The predominant mechanism of death in case of
meningococcal septic shock is circulatory failure. Inotropic requirements between patients
vary widely. We investigated whether polymorphisms in genes regulating the hemodynamic
response, influence the amount of inotropics required or the susceptibility to severe menin-
gococcal disease.
METHODS. In this retrospective case control study in our Pediatric Intensive Care Unit 56
cases (all consecutive patients admitted to the PICU between 1993 and 2001 with a proven
meningococcal infection) and 136 controls were included. Patients were divided in two
groups, according to their inotropic requirements. DNA analysis was performed to determine
the polymorphisms of the ADRB-1, ADRB2, alpha-adducin, ACE and ATR-1 genes.
RESULTS. For the alpha-adducin gene a significant difference of the genotype distribution
was found between the cases and controls. The odds ratio for admission to the PICU with
meningococcal sepsis with or without meningitis, for carriers of the variant allele (Gly460Trp
or Trp460Trp) was 2.1 (95% CI 1.11–4.04; p \ 0.02). Cases homozygote for the wild type
allele of the beta-1 adrenergic receptor at locus 389, were more likely to have a low prism
score on admission (OR 3.6 (95% CI 1.11–11.76). No difference was found in the distribution
of the ADRB-1, ADRB-2, ACE and ATR-1 polymorphisms between the two groups of
patients or between cases and controls.
CONCLUSIONS. Among patients admitted to the PICU with a meningococcal infection, the
variant allele of the alpha-adducin gene was more prevalent compared to controls. Patients
with the variant allele of the ADRB-1 at locus 389 were more likely to have a high PRISM
score on admission. In studies in adults the variant allele was associated with decreased renin
activity posing a possible explanation for our finding. Measuring plasma renin activity, AT I,
AT II, aldosteron synthesis and related polymorphisms will elucidate our hypothesis.
We did not find a difference in the frequencies of polymorphisms from the adrenergic receptor
genes, the ATR-1 gene or the ACE (I/D) polymorphism between cases and controls while
others found an increased mortality among carriers of the ACE D-allele in a comparable
population. We did not have access to the DNA of the deceased patients, which may have
influenced our results.
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LOW CD8 T-CELLS IN NEONATES AND INFANTS PRIOR TO SURGERY AND
HEALTHCARE-ASSOCIATED INFECTIONS: A PROSPECTIVE OBSERVA-
TIONAL STUDY
S. Grosek1, Z. Petrin2, A.N. Kopitar3, J. Grosek4, J. Erzen5, T. Stopar Gmeiner6,
M. Petreska1, J. Primozic1, A. Ihan3
1University Medical Centre Ljubljana, Department of Pediatric Surgery and Intensive Care,
Ljubljana, Slovenia, 2Department for Intensive Care Medicine, University Medical Center
Ljubljana, Ljubljana, Slovenia, 3Medical Faculty, University of Ljubljana, Institute of
Microbiology and Immunology, Ljubljana, Slovenia, 4University Medical Centre Ljubljana,
Department of Abdominal Surgery, Ljubljana, Slovenia, 5University Medical Centre
Ljubljana, Department of Thoracic Surgery, Ljubljana, Slovenia, 6University Medical Centre
Ljubljana, Department for Nuclear Medicine, Ljubljana, Slovenia
INTRODUCTION. Major surgery suppresses the cell-mediated immune response in adults
and children. Both; innate (HLA-DR monocytes/macrophages, NK cells) and adaptive cell-
mediated immune responses (T-cell populations) are affected following major surgery or
trauma. Cytotoxic T-cell lymphocytes (CD8 T-cells) fall significantly in neonates postopera-
tively, while predominantly helper T-cell lymphocytes (CD4 T-cells) are decreased in adult
patients and children. Low CD4 T-cell counts and an imbalance between their Th1/Th2 subsets
in adult patients following major surgery or trauma were associated with septic complications.
OBJECTIVES. Data about preoperative and postoperative counts of T-cell populations in
paediatric surgical patients and its relationship to healthcare-associated infection, HAI, are not
yet known.
METHODS. We conducted a prospective observational study on T-cell populations in
peripheral blood, immediately before and after, and in the first 3 days after surgery in 28 children
(13 neonates and 15 infants) and their relationship to healthcare-associated infection. Health-
care-associated infections were classified according to CDC/NHSN criteria. The study was
approved by the Slovenian Ethics Committee, and informed consent was obtained. The study
was conducted in the Level III Multidisciplinary Neonatal and Paediatric Intensive Care Unit in
the Department of Paediatric Surgery and Intensive Care, University Medical Centre Ljubljana,
Slovenia. During the study period, from January 2007 to May 2008, 28 out of 33 children were
included. Thirteen of the children were neonates, with a median (interquartile ranges, IQR) age
of 0 (0–2) days, and fifteen were infants, with a median (IQR) age of 5 (2.5–15.5) months.
RESULTS. Six out of 28 (21.4%) neonates and infants developed healthcare-associated
infection (Group I-HAI), while 22 out of 28 (78.6%) remained infection free (Group II-
nonHAI). No differences were found between the two groups with regard to age, weight,
gender, blood transfusion, anaesthetic technique and Oxford stress surgical score index. In
Group I with HAI presurgical median values of CD8-T-cells were found to be below normal
values for age. In addition, we found that median values (M) and interquartile ranges (IQR) of
cytotoxic CD8 T-cells were twice as low (358; 304–424 cells/mikrol) compared to Group II
withot HAI (822; 522–933 cells/microl; (p = 0.013)), while median values of CD8 T-cells in
Group I-HAI remained very low throughout the study period.
CONCLUSIONS. These results demonstrate that neonates and infants who underwent a
major surgical procedure and had very low values of CD8 T-cells preoperatively, developed
HAI postoperatively.
GRANT ACKNOWLEDGEMENT. This study was supported in part by research grant
TERCIAR 70242 from the University Medical Centre Ljubljana, Slovenia.
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ACCURACY OF THE BROSELOW TAPE, PALS FORMULA, MODIFIED PALS
FORMULA, FAMILY MEMBER ESTIMATION AND THE PERCENTILE 50TH OF
THE NATIONAL WEIGHT–HEIGHT CORRELATION GRAPH FOR THAI CHIL-
DREN’S WEIGHT ESTIMATION
S. Trakulsrichai1, C. Boonsri1, P. Chatchaipun2
1Ramathibodi Hospital Medical School, Emergency Department, Bangkok, Thailand,
2Ramathibodi Hospital Medical School, Section for Clinical Epidemiology and Biostatistics,
Research Center, Bangkok, Thailand
INTRODUCTION. Accurate children’s weight estimation is important for emergency care,
particularly for drug dosages, electrical therapy or equipment sizes. Weight is difficult to
measure in critically ill children. Several formulae or methods have been developed to
estimate children’s weight accurately. Most formulae or methods were developed from
western countries. The formulae or methods currently used might not fit with Thai children.
OBJECTIVES. To determine the accuracy of the Broselow tape, PALS formula, modified
PALS formula, family member estimation and the percentile 50th of the national weight–
height correlation graph for Thai children’s weight estimation.
METHODS. The author carried out a prospective cross-sectional study. Children from
neonate to 12 years old who presented to the emergency room and general out-patient
pediatric clinic were included. The patients were studied in both overall and subgroup
analysis (less than 10 kg, 10–25 kg, 25–40 kg and over 40 kg). The primary outcome was the
agreement within 10% of the measured weight and the mean difference.
RESULTS. 595 patients were included in this study. There were 333 (55.97%) boys and 262
(44.03%) girls. Family member estimation was the most accurate method with 85.21%
agreement within 10% of the measured weight and had the lowest mean difference
(-0.26 kg). Family members can estimate weight statistically and significantly accurate for
all weight subgroups. The Broselow tape was the most accurate method of other alternative
methods with 56.13% agreement within 10% of the measured weight and the lowest mean
difference (-0.49 kg). The Broselow tape had the best estimation in the weight subgroup less
than 10 kg. The agreement within 10% of the measured weight of the percentile 50th of the
national weight–height correlation graph were 51.43% and the mean difference were
-0.64 kg. The agreement within 10% of the measured weight of PALS and modified PALS
formulae were 38.99% and 39.55% respectively. The mean difference of PALS and modified
PALS formulae were -0.72 and -0.73 kg respectively.
CONCLUSIONS. Family member estimation of weight was the most accurate method in this
study. In cases of family member estimation not being available, the Broselow tape was the
most accurate alternative method however it could not estimate more than one-third of Thai
children accurately.
REFERENCE(S). 1. Black K, Barnett P, Wolfe R et al (2002) Are methods used to estimate
weight in children accurate? Emerg Med 14:160–165
2. Krieser D, Nguyen K, Kerr D, Jolley D, Clooney M, Kelly AM (2007) Parental weight
estimation of their child’s weight is more accurate than other weight estimation methods for
determining children’s weight in an emergency department? Emerg Med J 24(11):756–759
GRANT ACKNOWLEDGEMENT. Ramathibodi Hospital Medical School.
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GLUCOSE PARAMETERS, GLUCOSE VARIABILITY AND TARGET BLOOD
GLUCOSE IN PEDIATRIC TRAUMA PATIENTS
P. Durdik1, S. Nosal1, V. Zolak2, M. Fedor2, J. Buchanec3, P. Banovcin3
1Jessenius Faculty of Medicine Comenius University, Pediatric Intensive Care Unit, Martin,
Slovakia, 2University Hospital Martin, Pediatric Intensive Care Unit, Martin, Slovakia,
3Jessenius Faculty of Medicine Comenius University, Department of Children and Adoles-
cents, Martin, Slovakia
OBJECTIVES. Diabetes of injury with increased serum glucose levels has been associated
with higher mortality and poor outcome in severely injured children. Peak blood glucose
(BG), duration and intensity of hyperglycemia are independently associated with mortality in
PICU (Srinivasan 2004). Strict glucose control by intensive insulin therapy is beneficial.
However, higher frequency of severe hypoglycemia and positive metabolic effects of glucose
have to be mentioned. The aim of this study is to compare applicability of glucose parameters
and glucose variability in pediatric trauma patients and establish target BG in severely injured
children.
METHODS. prospective clinical study in 2008. 51 children, non diabetic, with Injury
Severity Score more than 15 and Pediatric Trauma Score less than 9 points were included.
Average age was 9.8 years (6.9–11.9, CI 95%). The mortality showed 13.7%. BG was
measured every 3 h by standard biochemical laboratory tests and compared with glucose
levels by daily calibrated glucometer. Pediatric scoring systems, predict death rate (PDR) and
parameters of hospitalization were collected. Peak BG and glucose intensity were used glu-
cose parameters. The hyperglycemic index, hypo/hyperglycemia ratio and hyperglycemic
difference described glucose variability. The nonparametric statistic methods (Spearman
correlation and Mann Whitney U test) were used for analysis.
RESULTS. Hyperglycemia over 110 mg/dl [6.1 mmol/l] was in 87.3% patients. Both cal-
culated glucose parameter did not show significant difference between survivals and
nonsurvivals. All parameters of glucose variability were significantly higher in nonsurvivals
(p \ 0.01). Positive statistical significant correlation between peak BG and PDR3 (Spearman
coefficient r = 0.661, p \ 0.01). Target BG in pediatric trauma patients was established from
peak BG and PDR3 correlation by using a linear regression analysis. 137 mg/l [7.6 mmol/l]
was calculated as optimal BG for risk of mortality lower than 15%.
CONCLUSION. Hyperglycemia is very common in injured children. Glucose variability
better reflects the outcome and prognosis in pediatric trauma patients. Higher difference of
glucose variability has been associated with higher mortality and severe organ failure. Cal-
culated target BG is higher than normal glucose level thus could reflect positive metabolic
effect of glucose in injured children and minimize severe hypoglycemic episodes.
Study supported by VEGA grant 1/4287/07 and Grant MZ SR 2006/35-UK-04
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RISK FACTORS OF DEATH IN SEVERE RESPIRATORY SYNCYTIAL VIRUS
INFECTION
A. Chakroun Bouziri1, A. Khaldi1, A. Hamdi1, A. Bezzine1, S. Bel Hadj1, K. Menif1, N. Ben
Jaballah1
1Children’s Hospital of Tunis, Pediatric Intensive Care Unit, Tunis, Tunisia
OBJECTIVE. Respiratory syncytial virus (RSV) has been found to be the most common
viral cause of death in children less than 1 year old. The purpose of this study was to
determine the mortality rate and the risk factors for death in children with severe RSV
infection.
METHODS. Retrospective review of the medical records of all children managed in a
tertiary pediatric intensive care unit (PICU) for severe RSV infection over a period of 9 years
(2000–2008). Need for mechanical ventilation (MV) or non invasive ventilatory support was
used as a marker of severity. To determine risk factors for death, a univariate then a multi-
variate analysis using a logistic regression model were performed.
RESULTS. During the study period, 142 patients (median age: 1, 4 months; interquartile
range (IQR): 0, 85–2, 4 months) had a severe RSV infection accounting for 3, 8% of total
admissions in the PICU and 84% of children managed for RSV infection. Of them 89, 5%
required MV and 10, 5% required non invasive respiratory support. Twelve children died
(median age: 2 months [IQR 0, 9–5, 1], median length of PICU stay: 17 days [IQR 8–34, 7])
and 130 survived (median age: 1, 4 months [IQR 0, 8–2, 4], median length of PICU stay:
9 days [IQR 5–16]). The overall PICU RSV mortality was 8, 4%. Death was caused by
refractory hypoxemia in 4 cases and refractory septic shock in 8 cases. All of the RSV deaths
had pre-existing or underlying medical conditions (prematurity: 5 cases, antecedent of neo-
natal respiratory distress: 5 cases requiring MV in 4 cases, chronic lung disease: 3 cases,
cardiac lesions: 3 cases, neuromuscular disease: 1 case) and 7 of them (58, 3%) were hyp-
otrophic. Risk factors for death in univariate analysis were: antecedent of neonatal respiratory
distress (41.7% vs 12.3%; p = 0.017), antecedent of MV during the neonatal period (33.3%
vs 3.8%; p = 0.003), occurrence of pulmonary air leak (33, 3% vs 5, 4%; p = 0.007),
occurrence of nosocomial infection (66.7% vs 20%; p = 0.001), prolonged MV (19.9 ± 14.6
vs 8.6 ± 6.9 days; p = 0.000) and prolonged length of stay (21 ± 15,8 vs 11.6 ± 11.5 days;
p = 0.009). Independent risk factors for death were: antecedent of MV during the neonatal
period (OR = 16, 9; 95% CI [2, 7–104]); prolonged MV in the PICU (OR = 12, 1; 95% CI
[1, 6–87]) and the occurrence of pulmonary air leak (OR = 9; 95% CI [1, 5–52]).
CONCLUSIONS. The mortality rate of severe RSV infection was 8, 4% in our PICU.
Antecedent of MV during the neonatal period; prolonged MV in the PICU and the occurrence
of pulmonary air leak are associated with a significantly higher risk of death from severe RSV
infection.
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